Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Pharmacogenetic considerations in the management of HIV infection
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacogenetic considerations in the management of HIV infection'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pharmacogenetics
100%
Antiviral Drugs
100%
HIV Patients
100%
HIV Infection
100%
Antiretroviral Therapy
50%
Drug Metabolism
50%
Drug Transport
50%
Drug Toxicity
50%
Virological Response
50%
Variable Drug Response
50%
Single nucleotide Polymorphism
25%
Inter-patient Variability
25%
Genetic Polymorphism
25%
Disease-related
25%
Pharmacologic
25%
P-glycoprotein (P-gp)
25%
Abacavir
25%
Virologic
25%
Antiretroviral
25%
Pharmacotherapy
25%
Drug Response
25%
Number of Factors
25%
Cytochrome
25%
Pharmacokinetic Differences
25%
Anti-HIV
25%
Human Leukocyte Antigen Genotyping
25%
Pharmacogenetic Study
25%
HLA-B*57
25%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacogenetics
100%
HIV
100%
Human Immunodeficiency Virus Infection
100%
Pharmacotherapy
75%
Drug Metabolism
50%
Drug Toxicity
50%
Disease
25%
P-Glycoprotein
25%
Abacavir
25%
Drug Transport
25%
Leukocyte Antigen
25%
Anti-Human Immunodeficiency Virus
25%
Cytochrome
25%
Allergic Reaction
25%
Pharmacokinetics
25%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus Infection
100%
Pharmacogenetics
100%
Drug Response
60%
Drug Metabolism
40%
Drug Toxicity
40%
Drug Transport
40%
Pharmacokinetics
20%
Single Nucleotide Polymorphism
20%
Human Leukocyte Antigen
20%
Hypersensitive Response
20%
Pharmacogenetic Testing
20%
P-Glycoprotein
20%
Genetic Polymorphism
20%